Intelligence Platform

Patents

Browse 67 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8580936

Polynucleotides encoding FGFR1-IIIc ECD fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575312

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501191

FGFR2-IIIb fusion proteins and methods of making them

Five Prime Therapeutics, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481038

Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445445

Method of promoting hair growth using FGFR4 extracellular domains

Five Prime Therapeutics, Inc. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431532

FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments u

Five Prime Therapeutics, Inc. · Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404810

Compositions and methods of use for modulators of polypeptides and polynucleotides in trea

Five Prime Therapeutics, Inc. · Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8338569

FGFR extracellular domain acidic region muteins

Five Prime Therapeutics, Inc. · Granted Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8324165

Compositions for treating arthritis comprising HG1023575 polypeptide

Five Prime Therapeutics, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8206715

Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

Five Prime Therapeutics, Inc. · Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8183207

Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molec

Five Prime Therapeutics, Inc. · Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8178109

Compositions and methods of use for MGD-CSF in disease treatment

Five Prime Therapeutics, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173134

ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

Five Prime Therapeutics, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8168588

Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditions

Five Prime Therapeutics, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080246

Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

Five Prime Therapeutics, Inc. · Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058403

Antibodies to stromal cell-derived factor-1 polypeptides

Five Prime Therapeutics, Inc. · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7982014

FGFR3-IIIc fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776564

Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and method

Five Prime Therapeutics, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7678890

Compositions and methods of treating disease with FGFR fusion proteins

Five Prime Therapeutics, Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted